The Changing Talent Profile in Commercial Analytics and Forecasting

Share it
Facebook
X
LinkedIn
Email

By Kyle Diamond, Principal, Pharmaceutical Practice, Penfield Search Partners

The Commercial talent market is gaining momentum as life sciences companies prepare for launches and build capabilities to support growth. BioSpace reported a 38% year-over-year increase in sales, marketing, and medical affairs postings, while Deloitte found that 48% of surveyed biopharma executives plan to focus on launching new therapies in 2026.

But more activity does not mean easier hiring. Companies remain highly selective, and professionals who combine Commercial judgment, analytical depth, and demonstrated business impact are still difficult to find.

The challenge: How do you find the talent that can help the business make better Commercial decisions?

Commercial Teams Need More Than Technical Analytics Expertise

As teams continue to evolve, demand is particularly strong across:

  • Commercial Analytics for in-market products and launch planning.
  • Sales Operations
  • Forecasting for inline products and pipeline assets

But expectations are changing. Reporting and dashboards are no longer enough, while functions such as Sales Operations are expanding into areas like targeting, segmentation, data strategy, and business insights. Companies need professionals who can interpret data, understand the business question, and translate insights into Commercial recommendations.

Strong candidates increasingly combine:

  • Commercial judgment
  • Technical and analytical capability
  • Cross-functional influence
  • Execution with measurable results

The question is shifting from “Can this person do the job?” to “Can this person make the function stronger?”

The Right Profile Depends on What the Business Needs to Build

The right talent profile can look very different depending on the organization:

  • Large pharma often needs specialists with deep expertise in areas such as Forecasting, Commercial Analytics, CRM, incentive compensation, Sales Operations, or a particular therapeutic area.
  • Emerging biopharma typically needs greater breadth, with professionals who can build forecasting processes, select vendors, partner with Finance, support sales-force design, and advise Commercial leadership through launch.

For emerging companies in particular, the ideal candidate is often a builder. Launch experience and the ability to create infrastructure may matter more than years spent maintaining a mature function. Defining that distinction early helps focus the search on what the business actually needs.

A Larger Candidate Pool Does Not Mean an Easier Search

More available candidates do not necessarily make critical Commercial roles easier to fill. The strongest professionals can clearly explain the business problem, the data behind it, their recommendation, and the outcome. Just as importantly, they can translate sophisticated analytics into action for Commercial leadership.

Strong candidates are also evaluating employers carefully, including:

  • The asset and its lifecycle stage
  • Commercial strategy and leadership
  • The role’s influence and resources
  • Whether they will build or maintain
  • Working model and flexibility

Companies risk losing top talent when a strategic role proves tactical, the process moves too slowly, or the organization cannot clearly explain why the position matters.

Defining the Need Is Often the Most Important Part of the Search

When a role encompasses multiple functions across Analytics, Forecasting, Operations, and Strategy, matching titles and keywords is rarely enough. This is often where Penfield Search Partners gets pulled into the conversation. The first step is understanding what the organization is trying to accomplish and determining whether the business needs a specialist, a builder, or someone capable of bridging both. That clarity helps shape a more realistic profile and a more focused search.

What’s Next for Commercial Talent?

Over the next 12 to 24 months, we expect Commercial hiring to become more specialized, with greater emphasis on professionals who can work across traditional functional boundaries.

  • Analytics, Forecasting, and Strategy will continue to converge, increasing demand for people who can connect data to business decisions.
  • Launch and builder experience will carry a premium, particularly as emerging companies move from development into commercialization.
  • Rare disease and specialty pharma expertise will remain highly valuable, given the complexity of patient identification, access, segmentation, field deployment, and forecasting.
  • Data and AI fluency will increasingly matter, especially for professionals who can apply claims, EHR, specialty pharmacy, CRM, and AI-enabled analytics to real Commercial problems. (That shift is already underway: Deloitte reports that 48% of executives see digital transformation as a major 2026 trend, yet only 22% have successfully scaled AI.)

The strongest Commercial talent will turn data into decisions and help build what comes next. For companies preparing for launch or building Commercial Analytics and Forecasting capabilities, Penfield Search Partners can help define the need and identify the right talent.

Visit www.penfieldsearch.com or connect with Kyle on LinkedIn  to start a conversation.


Share:

Facebook
Twitter
LinkedIn